As the U.S. Food and Drug Administration (FDA) proposed, Clene is concluding analyses of its ALS biomarker data with completion planned shortly ...
Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback